Return to Library
Congenital adrenal hyperplasia Visual Overview
Topic

Congenital adrenal hyperplasia

💡 What You Need to Know

  • Inherited Disorder: Congenital adrenal hyperplasia (CAH) is a group of inherited genetic disorders affecting the adrenal glands' ability to produce essential hormones.
  • Hormone Imbalance: It primarily results in insufficient cortisol production and often an overproduction of androgens (male hormones).
  • Common Form: The most prevalent type is 21-hydroxylase deficiency, accounting for over 90% of cases.
  • Presentation: CAH can manifest in classic forms (salt-wasting or simple virilizing) or a milder non-classic form.
  • Newborn Screening: Early detection through newborn screening for elevated 17-hydroxyprogesterone is crucial for timely intervention and preventing adrenal crises.

🤒 Associated Symptoms

  • Classic Salt-Wasting CAH: Severe vomiting, poor feeding, dehydration, lethargy, low blood pressure, hyponatremia, hyperkalemia, and ambiguous genitalia in female infants.
  • Classic Simple Virilizing CAH: Ambiguous genitalia in female infants, precocious puberty in males, rapid growth, and advanced bone age in childhood.
  • Non-Classic CAH (Later Onset): Hirsutism, acne, irregular menstrual cycles, premature pubarche, and potential infertility in females; early balding or testicular adrenal rest tumors in males.
  • Adrenal Crisis: Acute onset of severe vomiting, diarrhea, profound weakness, shock, hypoglycemia, and electrolyte imbalances, requiring immediate medical attention.

🛡 Crucial Precautions

  • Lifelong Medication Adherence: Strict and consistent adherence to prescribed glucocorticoid (e.g., hydrocortisone) and mineralocorticoid (e.g., fludrocortisone) replacement therapy is vital.
  • Stress Dosing Protocol: Always increase glucocorticoid dosage during periods of illness, fever, surgery, or significant physical/emotional stress as directed by an endocrinologist to prevent adrenal crisis.
  • Emergency Preparedness: Carry an emergency injectable hydrocortisone kit and wear medical alert identification indicating CAH and steroid dependency.
  • Regular Endocrine Monitoring: Maintain regular follow-up appointments for monitoring electrolyte levels, renin activity, 17-hydroxyprogesterone, and growth parameters.
  • Genetic Counseling: Seek genetic counseling for affected individuals and their families to understand inheritance patterns and reproductive risks.

🍽 Dietary Directions & Restrictions

  • Sodium Supplementation: Patients with salt-wasting CAH may require additional sodium intake, especially during illness, hot weather, or strenuous activity, under medical supervision.
  • Adequate Hydration: Ensure consistent and sufficient fluid intake, particularly during periods of illness or increased physical demand, to support overall health and prevent dehydration.
  • Balanced Nutrition: Promote a well-balanced diet to support healthy growth and development, as chronic conditions can impact nutritional status.
  • Avoid Unverified Supplements: Exercise caution and consult a physician before using any herbal remedies or dietary supplements that claim to support adrenal function, as they may interfere with prescribed medications.

⚠️ Attendant Guidelines

  • Recognize Adrenal Crisis: Educate all caregivers (parents, school staff, babysitters) on the signs and symptoms of an impending adrenal crisis and the immediate steps to take.
  • Emergency Action Plan: Ensure a clear, written emergency plan is accessible, detailing medication dosages, stress-dosing instructions, and emergency contact information.
  • Medical Identification: Encourage the patient to wear a medical alert bracelet or necklace clearly stating their diagnosis of CAH and steroid dependency.
  • Medication Storage: Store all medications, especially emergency hydrocortisone, safely and ensure they are not expired.
  • School and Travel Plans: Inform school personnel and travel companions about the condition and the necessary precautions, including emergency medication.

🩺 Physician's Perspective

  • Lifelong Management: CAH is a chronic condition requiring lifelong medical management, patient education, and close monitoring to optimize health outcomes.
  • Individualized Treatment: Treatment regimens, including glucocorticoid and mineralocorticoid doses, must be highly individualized and adjusted based on age, growth, pubertal status, and biochemical markers.
  • Psychosocial Support: Address the significant psychosocial impact of CAH, particularly concerning body image, gender identity, and fertility, by providing appropriate counseling and support.
  • Multidisciplinary Care: Advocate for a multidisciplinary team approach involving pediatric endocrinologists, geneticists, urologists/gynecologists, and mental health professionals.
  • Preventive Care: Emphasize the importance of regular health check-ups, vaccinations, and prompt treatment of intercurrent illnesses to prevent adrenal crises.

🎓 Academic & Nursing Corner

  • Newborn Screening Interpretation: Understand the significance of elevated 17-hydroxyprogesterone levels in newborn screening and the need for confirmatory testing.
  • Adrenal Crisis Intervention: Be proficient in the rapid assessment and management of adrenal crisis, including the administration of parenteral hydrocortisone and fluid resuscitation.
  • Patient and Family Education: Provide comprehensive education on medication administration, stress dosing, monitoring for signs of adrenal insufficiency or excess, and the importance of medical alert identification.
  • Growth and Development Monitoring: Accurately track growth velocity, bone age, and pubertal development as key indicators of treatment efficacy and potential complications.
  • Psychosocial Assessment: Conduct sensitive assessments of the patient's and family's psychosocial well-being, offering support and referrals as needed.

🔬 Clinical Reference Index

  • Genetic Basis: Autosomal recessive inheritance, most commonly due to mutations in the *CYP21A2* gene encoding 21-hydroxylase.
  • Key Biochemical Markers: Elevated 17-hydroxyprogesterone (17-OHP), androstenedione, and testosterone; low cortisol; elevated plasma renin activity (in salt-wasting forms).
  • Primary Treatment Modalities: Glucocorticoid replacement (e.g., hydrocortisone, prednisone, dexamethasone) and mineralocorticoid replacement (fludrocortisone) with sodium supplementation as needed.
  • Diagnostic Confirmation: ACTH stimulation test to confirm 21-hydroxylase deficiency in ambiguous cases, particularly non-classic forms.
  • Surgical Considerations: Genital reconstructive surgery for females with ambiguous genitalia, typically performed in infancy or early childhood, with careful consideration of timing and patient/family preferences.